Topic

Drugs

8
Feb
2016

Why Patents Are Sometimes Overrated

You could get the impression, reading about the patent fight over the CRISPR-Cas9 genome editing, that patents are the only thing that matter in biotech. Once the courts sort out who the rightful inventors are, that’s that. The winner gets fame and fortune. Losers get a set of steak knives, or fired. All or nothing. This is a reasonable view...
Read More